Off Label Use has been reported as an adverse reaction across 24 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 29,412 adverse event reports mention off label use in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with off label use, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
Haleon Us Holdings Llc Drugs Reporting Off Label Use
The following Haleon Us Holdings Llc drugs have off label use listed in their FDA adverse event reports, sorted by report count:
Which Haleon Us Holdings Llc drugs cause Off Label Use?
24 drug(s) manufactured by Haleon Us Holdings Llc have off label use listed in their FDA adverse event reports: DICLOFENAC SODIUM, CALCIUM CARBONATE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, IBUPROFEN SODIUM, and others.
How many Off Label Use reports are there for Haleon Us Holdings Llc drugs?
There are a combined 29,412 reports of off label use across 24 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.